Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease
Cell · 2025-05 · 188 (11) · 3030-3044.e17
DOI: 10.1016/j.cell.2025.03.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025-05. Verfasst von Yiwen Hou und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of USTC, Hefei National Research Center for Physical Sciences at the Microscale, National Key…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Major Science and Technology Projects of China, Anhui Provincial Department of Education, Scientific Research Foundation of Education Department of Anhui Province of China.
Abstract (Originalsprache)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a cornerstone treatment for a broad spectrum of malignant and nonmalignant hematological disorders. However, the success of allo-HSCT is often overshadowed by acute graft-versus-host disease (aGVHD), a life-threatening complication. Here, we show in patients and murine models that the circadian timing of stem cell infusion dictates the development of aGVHD. Early-infused patients exhibit a significantly lower incidence and severity of aGVHD, as well as improved survival. We observed time-of-day variations in the levels of cytokines, especially IL-1α, which controls donor T cell responses after transplantation. The levels of IL-1α in patients were strongly associated with the development of aGVHD. Furthermore, preclinical results showed that the administration of IL-1α neutralizing antibodies markedly alleviated aGVHD and increased survival. Our study suggests that scheduling stem cell infusions early in the day could be a simple yet transformative intervention for preventing aGVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of USTC, Hefei National Research Center for Physical Sciences at the Microscale, National Key Laboratory of Immune Response and Immunotherapy, Division of Life Sci…
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Blood and Marrow Transplantation Center, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shangha…
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, Chin…
- Department of Pediatrics, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
- Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.
Förderung
- National Major Science and Technology Projects of China
- Anhui Provincial Department of Education
- Scientific Research Foundation of Education Department of Anhui Province of China
- Natural Science Foundation of Anhui Province
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Hou, Y., Wu, Y., Cao, Y., Hu, X., Sun, Y., Wang, H., Wang, L., Zhou, J., Zhang, Z., Liu, Z., Tang, B., Song, K., Sun, G., Gao, W., Zheng, T., Wu, P., Wu, W., Ju, D., Zhu, X., & Zhan, C. (2025). Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease. Cell, 188(11), 3030-3044.e17. https://doi.org/10.1016/j.cell.2025.03.022
Vancouver
Hou Y, Wu Y, Cao Y, Hu X, Sun Y, Wang H, et al. Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease. Cell. 2025;188(11):3030-3044.e17. doi:10.1016/j.cell.2025.03.022
BibTeX
@article{Hou2025,
author = {Hou, Yiwen and Wu, Yue and Cao, Yang and Hu, Xiaoxia and Sun, Yuqian and Wang, Hongmei and Wang, Liang and Zhou, Jialin and Zhang, Zhonglin and Liu, Zhiwei and Tang, Baolin and Song, Kaidi and Sun, Guangyu and Gao, Wen and Zheng, Tianqi and Wu, Ping and Wu, Weiwei and Ju, Dapeng and Zhu, Xiaoyu and Zhan, Cheng},
title = {Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease},
journal = {Cell},
year = {2025},
volume = {188},
number = {11},
pages = {3030--3044.e17},
doi = {10.1016/j.cell.2025.03.022}
}
EUVIMED